A Novel Cell Death Pathway Induced by Galectin-1
A Novel Cell Death Pathway Induced by Galectin-1
批准号:
6753612
负责人:
Linda G Baum
金额:
$25.86万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-09-01 至 2005-05-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Cell death is a critical regulatory
process in development, in homeostasis, and in disease. Many cell death
triggers have been identified, although little is known about many of the
molecular pathways that lead to cell death. Galectin-1, a member of a family of
evolutionarily ancient lectins, induces death of thymocytes and T-cells. In
mammals, galectin-1 is expressed in lymphoid tissues, at sites of inflammation,
and in some types of cancer. Galectin-1 has also been shown to be
immunosuppressive in several animal models of autoimmune disease. Galectin-1
induces cell death of transformed epithelial cells as well, so that galectin-1
mediated cell death may be a fundamental mechanism that regulates cell survival
in many tissues. Other galectin family members have pro- or anti-apoptotic
activities in different tissues, suggesting that different galectins may
cooperate to regulate cell death. The goal of this application is to
characterize the molecular mechanism of galectin-1 cell death, to understand
the interaction of galectin-1 with glycoprotein receptors on the cell surface,
and the downstream events that regulate cell death.
The Specific Aims are:
1. To define features of the T-cell surface receptors for galectin-l required
to transmit the death signal. CD7 and CD43 are glycoprotein receptors for
galectin-1. Features of the glycans and the polypeptides that are essential for
sending the death signal will be identified.
2. To examine how galectin-l binding to T-cells results in molecular
interactions to deliver the death signal. Galectin-1 binding results in a
unique pattern of receptor reorganization on the T-cell surface. We will
identify features of the receptors required for this interaction, and
investigate whether receptor reorganization is required for cell death. Effects
of galectin-1 on cytoskeletal linker proteins and on the actin cytoskeleton
will be characterized. To examine cell-cell interactions that govern T-cell
death, receptor reorganization during galectin-1 mediated binding of T-cells to
thymic stromal cells will be examined.
3. To characterize intracellular components that regulate the galectin-l cell
death pathway.
We will examine the roles of the protein kinase C and protein phosphatase
families of enzymes in regulating galectin1 cell death. We determine how
galectin-3 expression regulates T-cell susceptibility to galectin-1.
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
New roles for galectins in brain tumors--from prognostic markers to therapeutic targets.
半乳糖凝集素在脑肿瘤中的新作用——从预后标志物到治疗靶点。
DOI:
10.1111/j.1750-3639.2005.tb00507.x
发表时间:
2005
期刊:
Brain pathology (Zurich, Switzerland)
影响因子:
--
作者:
[Stillman,BriannaN, Mischel,PaulS, Baum,LindaG]
通讯作者:
Baum,LindaG
CD45-mediated fodrin cleavage during galectin-1 T cell death promotes phagocytic clearance of dying cells.
半乳糖凝集素 1 T 细胞死亡过程中 CD45 介导的胞因子裂解促进垂死细胞的吞噬清除。
DOI:
10.4049/jimmunol.0804329
发表时间:
2009
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Pang,Mabel, He,Jiale, Johnson,Pauline, Baum,LindaG]
通讯作者:
Baum,LindaG
Preparation of recombinant human galectin-1 and use in T-cell death assays.
重组人半乳糖凝集素-1 的制备及其在 T 细胞死亡测定中的应用。
DOI:
10.1016/s0076-6879(03)01075-9
发表时间:
2003
期刊:
Methods in enzymology.
影响因子:
--
作者:
[Pace,KarenE, Hahn,HejinP, Baum,LindaG]
通讯作者:
Baum,LindaG
Regulation of inflammatory cell migration in asthma
-
批准号:8063630
-
项目类别:
-
资助金额:$19.25万
-
财政年份:2010
-
负责人:Linda G Baum
-
依托单位:
Regulation of inflammatory cell migration in asthma
-
批准号:7911394
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2010
-
负责人:Linda G Baum
-
依托单位:
Overcoming tumor cell resistance to apoptosis with a natural product, GCS-100
-
批准号:7821317
-
项目类别:
-
资助金额:$16.94万
-
财政年份:2009
-
负责人:Linda G Baum
-
依托单位:
Overcoming tumor cell resistance to apoptosis with a natural product, GCS-100
-
批准号:7640481
-
项目类别:
-
资助金额:$20.33万
-
财政年份:2009
-
负责人:Linda G Baum
-
依托单位:
Nipah Virus Pathobiology and Effects on Innate Immunity
-
批准号:7027741
-
项目类别:
-
资助金额:$37.72万
-
财政年份:2005
-
负责人:Linda G Baum
-
依托单位:
Nipah Virus Pathobiology and Effects on Innate Immunity
-
批准号:6915278
-
项目类别:
-
资助金额:$38.54万
-
财政年份:2005
-
负责人:Linda G Baum
-
依托单位:
Nipah Virus Pathobiology and Effects on Innate Immunity
-
批准号:7406028
-
项目类别:
-
资助金额:$35.93万
-
财政年份:2005
-
负责人:Linda G Baum
-
依托单位:
Nipah Virus Pathobiology and Effects on Innate Immunity
-
批准号:7214116
-
项目类别:
-
资助金额:$36.62万
-
财政年份:2005
-
负责人:Linda G Baum
-
依托单位:
Nipah Virus Pathobiology and Effects on Innate Immunity
-
批准号:7569493
-
项目类别:
-
资助金额:$35.93万
-
财政年份:2005
-
负责人:Linda G Baum
-
依托单位:
A Novel Cell Death Pathway Induced by Galectin-1
-
批准号:6370407
-
项目类别:
-
资助金额:$25.95万
-
财政年份:1997
-
负责人:Linda G Baum
-
依托单位:
A Novel Cell Death Pathway Induced by Galectin-1
-
批准号:6636669
-
项目类别:
-
资助金额:$25.86万
-
财政年份:1997
-
负责人:Linda G Baum
-
依托单位:
GALECTIN-1 INDUCES CELLULAR APOPTOSIS
-
批准号:2672815
-
项目类别:
-
资助金额:$17.55万
-
财政年份:1997
-
负责人:Linda G Baum
-
依托单位:
GALECTIN-1 INDUCES CELLULAR APOPTOSIS
-
批准号:2004859
-
项目类别:
-
资助金额:$17.02万
-
财政年份:1997
-
负责人:Linda G Baum
-
依托单位:
GALECTIN-1 INDUCES CELLULAR APOPTOSIS
-
批准号:2887251
-
项目类别:
-
资助金额:$18.18万
-
财政年份:1997
-
负责人:Linda G Baum
-
依托单位:
A Novel Cell Death Pathway Induced by Galectin-1
-
批准号:6520516
-
项目类别:
-
资助金额:$25.87万
-
财政年份:1997
-
负责人:Linda G Baum
-
依托单位:
海外基金